Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Pringle Way
Suite 706
Reno, NV 89502Phone+1 775-982-5770- Is this information wrong?
Summary
- I am a board-certified urologist with fellowship training in minimally invasive urologic oncology. My clinical expertise is in robotic surgery for urologic cancers, including Retzius-sparing prostatectomy, retroperitoneal partial nephrectomy, and intracorporeal urinary diversion during cystectomy. My research focus is in novel imaging and biomarkers for prostate cancer diagnosis and management. Our multidisciplinary research team has secured NIH funding for artificial intelligence models applied to novel MRI sequences to improve prostate cancer diagnosis and management (R01-CA258690, R01-CA282022).
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Minimally Invasive Urologic Surgery, 2017 - 2018- Washington University/B-JH/SLCH ConsortiumResidency, Urology, 2013 - 2017
- Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 2012 - 2013
- Washington University in St. Louis School of MedicineClass of 2012
Certifications & Licensure
IL State Medical License 2020 - 2026
CA State Medical License 2016 - 2026
MO State Medical License 2017 - 2025
NV State Medical License 2024 - 2025- American Board of Urology Urology
Clinical Trials
- Diffusion Basis Spectrum Imaging of the Prostate Start of enrollment: 2020 Feb 27
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 17 citationsPresence of Magnetic Resonance Imaging Suspicious Lesion Predicts Gleason 7 or Greater Prostate Cancer in Biopsy-Naive Patients.John Weaver, Eric H. Kim, Joel Vetter, Kathryn J. Fowler, Cary Siegel
Urology. 2016-02-01 - 34 citationsDetermination of the Role of Negative Magnetic Resonance Imaging of the Prostate in Clinical Practice: Is Biopsy Still Necessary?Robert Wang, Eric H. Kim, Joel Vetter, Kathryn J. Fowler, Anup S. Shetty
Urology. 2017-04-01 - 44 citationsUrine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.Pradeep S. Chauhan, Kevin Chen, Ramandeep K. Babbra, Wenjia Feng, Nadja Pejovic
Plos Medicine. 2021-08-31
Press Mentions
UroToday - Prostate Cancer Risk StratificationMay 10th, 2024
Grant Support
- Identifying Lethal Prostate Cancer at Diagnosis with Advanced Proteoglycomic, Radiomic, and Genomic approaches.NIH2023–2028
- Diffusion Histology Imaging: A Clinical Tool to Non-Invasively Diagnose and Manage Prostate CancerNIH2022–2026
Committees
- Member, AUA Research Grants and Investigator Support 2024 - Present
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
